IL117228A - Process for preparing loracarbef monohydrate - Google Patents

Process for preparing loracarbef monohydrate

Info

Publication number: IL117228A
Authority: IL; Israel
Prior art keywords: preparing; loracarbef monohydrate; loracarbef; monohydrate; preparing loracarbef
Prior art date: 1995-03-01

Application number

IL11722896A

Other languages

English (en)

Other versions

IL117228A0 (en

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-01

Filing date

1996-02-22

Publication date

2000-12-06

1996-02-22 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1996-06-18 Publication of IL117228A0 publication Critical patent/IL117228A0/xx

2000-12-06 Publication of IL117228A publication Critical patent/IL117228A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IL11722896A 1995-03-01 1996-02-22 Process for preparing loracarbef monohydrate IL117228A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/396,948 US5580977A (en)	1995-03-01	1995-03-01	Process for preparing loracarbef monohydrate

Publications (2)

Publication Number	Publication Date
IL117228A0 IL117228A0 (en)	1996-06-18
IL117228A true IL117228A (en)	2000-12-06

Family

ID=23569249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL11722896A IL117228A (en)	1995-03-01	1996-02-22	Process for preparing loracarbef monohydrate

Country Status (28)

Country	Link
US (1)	US5580977A (no)
EP (1)	EP0729959B1 (no)
JP (1)	JPH11501032A (no)
KR (1)	KR19980702666A (no)
CN (1)	CN1061349C (no)
AR (1)	AR002709A1 (no)
AT (1)	ATE184006T1 (no)
AU (1)	AU694639B2 (no)
BR (1)	BR9607308A (no)
CA (1)	CA2213812A1 (no)
CO (1)	CO4700429A1 (no)
CZ (1)	CZ272897A3 (no)
DE (1)	DE69603995T2 (no)
DK (1)	DK0729959T3 (no)
ES (1)	ES2135165T3 (no)
GR (1)	GR3031947T3 (no)
HU (1)	HUP9702151A3 (no)
IL (1)	IL117228A (no)
NO (1)	NO308471B1 (no)
NZ (1)	NZ304534A (no)
PE (1)	PE28097A1 (no)
PL (1)	PL322111A1 (no)
RU (1)	RU2160261C2 (no)
SI (1)	SI0729959T1 (no)
TR (1)	TR199700877T1 (no)
TW (1)	TW330205B (no)
WO (1)	WO1996026942A1 (no)
ZA (1)	ZA961341B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100540046B1 (ko)	1997-11-12	2006-01-10	미쓰비시 가가꾸 가부시키가이샤	퓨린유도체 및 이를 유효성분으로 함유하는 의약
WO2000068231A1 (fr)	1999-05-11	2000-11-16	Mitsubishi Chemical Corporation	Dihydrate derive de purine, medicaments le contenant comme principe actif et intermediaire utilise dans sa preparation
US6410520B2 (en)	2000-02-01	2002-06-25	The Procter & Gamble Company	Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
PE20011065A1 (es)	2000-02-01	2001-11-21	Procter & Gamble	Proceso para fabricar bisfosfonatos geminales
US20060205938A1 (en) *	2002-11-21	2006-09-14	Yatendra Kumar	Monohydrate solvates of loracarbef

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3502663A (en) *	1969-04-21	1970-03-24	Lilly Co Eli	Crystalline cephalosporin,method for its manufacture
US3531481A (en) *	1969-04-21	1970-09-29	Lilly Co Eli	Method for manufacture of crystalline cephalosporin
US4775751A (en) *	1985-06-03	1988-10-04	Eli Lilly & Company	Process for cephalexin hydrochloride alcoholates
DD273634A5 (de) *	1987-10-06	1989-11-22	��@��@��@��k��	Verfahren zur herstellung eines kristallinen monohydrats eines 1-carbacephalosporins
CA2002596A1 (en) *	1988-11-14	1990-05-14	Thomas M. Eckrich	Hydrates of b-lactam antibiotic
US4977257A (en) *	1988-11-14	1990-12-11	Eli Lilly And Company	DMF solvates of a β-lactam antibiotic
US5374719A (en) *	1993-06-04	1994-12-20	Eli Lilly And Company	Process for converting loracarbef dihydrate to loracarbef monohydrate
US5352782A (en) *	1993-06-04	1994-10-04	Eli Lilly And Company	Process for preparing crystalline β-lactam monohydrate
US5399686A (en) *	1993-06-04	1995-03-21	Eli Lilly And Company	Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate

1995
- 1995-03-01 US US08/396,948 patent/US5580977A/en not_active Expired - Lifetime
1996
- 1996-02-20 ZA ZA9601341A patent/ZA961341B/xx unknown
- 1996-02-21 AR ARP960101460A patent/AR002709A1/es not_active Application Discontinuation
- 1996-02-22 IL IL11722896A patent/IL117228A/xx active IP Right Grant
- 1996-02-24 TW TW085102100A patent/TW330205B/zh active
- 1996-02-26 CO CO96008863A patent/CO4700429A1/es unknown
- 1996-02-26 PE PE1996000129A patent/PE28097A1/es not_active Application Discontinuation
- 1996-02-27 DK DK96301303T patent/DK0729959T3/da active
- 1996-02-27 EP EP96301303A patent/EP0729959B1/en not_active Expired - Lifetime
- 1996-02-27 AT AT96301303T patent/ATE184006T1/de not_active IP Right Cessation
- 1996-02-27 DE DE69603995T patent/DE69603995T2/de not_active Expired - Fee Related
- 1996-02-27 SI SI9630108T patent/SI0729959T1/xx not_active IP Right Cessation
- 1996-02-27 ES ES96301303T patent/ES2135165T3/es not_active Expired - Lifetime
- 1996-02-28 HU HU9702151A patent/HUP9702151A3/hu unknown
- 1996-02-28 AU AU51742/96A patent/AU694639B2/en not_active Ceased
- 1996-02-28 CA CA002213812A patent/CA2213812A1/en not_active Abandoned
- 1996-02-28 RU RU97116165/04A patent/RU2160261C2/ru active
- 1996-02-28 PL PL96322111A patent/PL322111A1/xx unknown
- 1996-02-28 NZ NZ304534A patent/NZ304534A/en unknown
- 1996-02-28 WO PCT/US1996/002586 patent/WO1996026942A1/en not_active Application Discontinuation
- 1996-02-28 TR TR97/00877T patent/TR199700877T1/xx unknown
- 1996-02-28 CN CN96193438A patent/CN1061349C/zh not_active Expired - Fee Related
- 1996-02-28 BR BR9607308A patent/BR9607308A/pt not_active Application Discontinuation
- 1996-02-28 KR KR1019970706072A patent/KR19980702666A/ko active IP Right Grant
- 1996-02-28 JP JP8526365A patent/JPH11501032A/ja not_active Ceased
- 1996-02-28 CZ CZ972728A patent/CZ272897A3/cs unknown
1997
- 1997-08-20 NO NO973835A patent/NO308471B1/no not_active IP Right Cessation
1999
- 1999-11-25 GR GR990403040T patent/GR3031947T3/el unknown

Also Published As

Publication number	Publication date
PE28097A1 (es)	1997-08-20
AU5174296A (en)	1996-09-18
EP0729959A1 (en)	1996-09-04
AU694639B2 (en)	1998-07-23
CN1182429A (zh)	1998-05-20
HUP9702151A3 (en)	2001-01-29
KR19980702666A (ko)	1998-08-05
HUP9702151A2 (hu)	1998-07-28
BR9607308A (pt)	1997-11-25
TR199700877T1 (xx)	1998-02-21
CZ272897A3 (cs)	1998-01-14
CN1061349C (zh)	2001-01-31
NO308471B1 (no)	2000-09-18
NO973835D0 (no)	1997-08-20
WO1996026942A1 (en)	1996-09-06
NZ304534A (en)	1998-09-24
GR3031947T3 (en)	2000-03-31
NO973835L (no)	1997-08-20
PL322111A1 (en)	1998-01-05
CA2213812A1 (en)	1996-09-06
ES2135165T3 (es)	1999-10-16
IL117228A0 (en)	1996-06-18
RU2160261C2 (ru)	2000-12-10
US5580977A (en)	1996-12-03
CO4700429A1 (es)	1998-12-29
DE69603995T2 (de)	2000-01-20
AR002709A1 (es)	1998-04-29
DK0729959T3 (da)	1999-12-13
ATE184006T1 (de)	1999-09-15
SI0729959T1 (en)	1999-12-31
EP0729959B1 (en)	1999-09-01
JPH11501032A (ja)	1999-01-26
ZA961341B (en)	1997-08-20
DE69603995D1 (de)	1999-10-07
TW330205B (en)	1998-04-21
MX9706606A (es)	1997-11-29

Publication	Publication Date	Title
CZ252597A3 (cs)	1998-01-14	Způsob výroby azacyklohexapeptidů
HUP9800615A3 (en)	2000-04-28	Process for producing bis-hydroxy-methyl derivatives
HUP9900318A3 (en)	2001-09-28	Process for preparing 4-aryl-piperidine derivatives
HU9602681D0 (en)	1996-11-28	Process for producing new hydroxy-pyridinone derivatives
EP0714905A3 (en)	1996-10-02	Process for the preparation of trehalose derivatives
NZ313165A (en)	1999-05-28	Process for producing n-substituted 3-hydroxypyrazoles
EG24221A (en)	2008-11-10	Process for preparing olanzapine
IL118992A (en)	2000-06-01	Process for preparing norbenzomorphan derivatives
IL117228A (en)	2000-12-06	Process for preparing loracarbef monohydrate
HUP9701013A3 (en)	2001-04-28	Process for producing cephem-and isooxacephem derivatives
HUP9602960A2 (en)	1997-10-28	Process for producing alkylcarbazates
NZ321968A (en)	1999-05-28	Process for preparing dioxoazabicyclohexanes
HUP9602988A3 (en)	1998-01-28	Process for producing 2-chloracrylnitril
GR3030254T3 (en)	1999-08-31	Process for preparing substituted aminotriazolinones
EP0751112A3 (de)	1997-09-10	Verfahren zur Herstellung von Arylidensubstituierten Alkylcycloalkanonen
HUP9802646A3 (en)	2001-11-28	Process for producing formylimidazol derivatives
HU9701137D0 (en)	1997-08-28	Process for producing pharmaceutical intermedier
HU9702176D0 (en)	1998-01-28	New process for producing lisinoprile
GB9613005D0 (en)	1996-08-21	Process for preparing 4-tert-butyloxycarbonyl-(s)-piperazine-2-tert-butylcarboxamide
HUP9800372A3 (en)	2001-02-28	Process for producing trans-phenyl-glycidyl-acid derivatives
HU9503733D0 (en)	1996-02-28	Process for producing veratrumaldehyde
GB9424890D0 (en)	1995-02-08	Process for preparing pyrolizine derivatives
HUP9801592A3 (en)	2001-05-28	Process for preparing substituted aryluracils
KR0159833B1 (en)	1998-12-01	Novel process for preparing cephalosporin derivatives
ZA964976B (en)	1997-01-23	Process for preparing triazole derivatives

Legal Events

Date	Code	Title	Description
2001-04-30	FF	Patent granted